Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens - Concepedia

Concepedia

Publication | Open Access

Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens

DOI Full Paper Access

75

Citations

43

References

2015

Year

Cynthia M. Fehres, Hakan Kalay, Sven C. M. Bruijns, Sara A M Musaafir, Martino Ambrosini, Louis van Bloois, Sandra J. van Vliet, Gert Storm, Juan J. García‐Vallejo, Yvette van Kooyk

Journal of Controlled Release

Immunocytochemical TechniqueImmunologyTherapeutic VaccineDifferent FormulationsAntibody EngineeringGlycan-modified AntigensImmunotherapyMedicineRadiation OncologyTumor Microenvironment

References

	Year	Citations

Page 1

Page 1